D J Bean1,2, M H Johnson2, W Heiss-Dunlop3, R R Kydd2. 1. The Auckland Regional Pain Service (TARPS), Auckland District Health Board, New Zealand. 2. Department of Psychological Medicine, The University of Auckland, New Zealand. 3. Auckland Regional Plastic Reconstructive and Hand Surgery Service, Counties Manukau District Health Board, New Zealand.
Abstract
BACKGROUND: The literature concerning the outcomes of complex regional pain syndrome (CRPS) is contradictory, with some studies suggesting high rates of symptom resolution, whilst others demonstrate that CRPS symptoms can persist and lead to significant disability. The aim of the present study was to carefully document the extent of recovery from each of the signs and symptoms of CRPS. METHODS: A sample of 59 patients with recently onset (<12 weeks) CRPS-1 were followed prospectively for 1 year, during which time they received treatment-as-usual. At baseline, 6 and 12 months, the following were measured: CRPS severity scores (symptoms and signs of CRPS), pain, disability, work status and psychological functioning. RESULTS: Analyses showed that rates of almost all signs and symptoms of CRPS reduced significantly over 1 year. Reductions in symptom severity were clinically relevant and were greatest in the first 6 months and plateaued thereafter. However, at 1 year, nearly 2/3 of patients continued to meet the IASP-Orlando criteria for CRPS and 1/4 met the Budapest research criteria for CRPS. Only 5.4% of patients were symptom-free at 12 months. CONCLUSIONS: Overall the results were less optimistic than several previously conducted prospective studies and suggest that few cases of CRPS resolve completely within 12 months of onset. Improvements were generally greater in the first 6 months, and suggest that it may be worth exploring early interventions to prevent long-term disability in CRPS.
BACKGROUND: The literature concerning the outcomes of complex regional pain syndrome (CRPS) is contradictory, with some studies suggesting high rates of symptom resolution, whilst others demonstrate that CRPS symptoms can persist and lead to significant disability. The aim of the present study was to carefully document the extent of recovery from each of the signs and symptoms of CRPS. METHODS: A sample of 59 patients with recently onset (<12 weeks) CRPS-1 were followed prospectively for 1 year, during which time they received treatment-as-usual. At baseline, 6 and 12 months, the following were measured: CRPS severity scores (symptoms and signs of CRPS), pain, disability, work status and psychological functioning. RESULTS: Analyses showed that rates of almost all signs and symptoms of CRPS reduced significantly over 1 year. Reductions in symptom severity were clinically relevant and were greatest in the first 6 months and plateaued thereafter. However, at 1 year, nearly 2/3 of patients continued to meet the IASP-Orlando criteria for CRPS and 1/4 met the Budapest research criteria for CRPS. Only 5.4% of patients were symptom-free at 12 months. CONCLUSIONS: Overall the results were less optimistic than several previously conducted prospective studies and suggest that few cases of CRPS resolve completely within 12 months of onset. Improvements were generally greater in the first 6 months, and suggest that it may be worth exploring early interventions to prevent long-term disability in CRPS.
Authors: Frank Birklein; Seena K Ajit; Andreas Goebel; Roberto S G M Perez; Claudia Sommer Journal: Nat Rev Neurol Date: 2018-03-16 Impact factor: 42.937
Authors: Sharon Grieve; Roberto S G M Perez; Frank Birklein; Florian Brunner; Stephen Bruehl; R Norman Harden; Tara Packham; Francois Gobeil; Richard Haigh; Janet Holly; Astrid Terkelsen; Lindsay Davies; Jennifer Lewis; Ilona Thomassen; Robyn Connett; Tina Worth; Jean-Jacques Vatine; Candida S McCabe Journal: Pain Date: 2017-06 Impact factor: 6.961
Authors: Yohannes W Woldeamanuel; Corinne Cooley; Katharine Foley-Saldena; Robert P Cowan Journal: Biomed Res Int Date: 2017-10-30 Impact factor: 3.411